Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Uterine Cervical Neoplasms 31Prostatic Neoplasms 17Breast Neoplasms 8Sarcoma 6Vaginal Neoplasms 4Neoplasms 4Endometrial Neoplasms 4Vulvar Neoplasms 3Uterine Neoplasms 3Lung Neoplasms 3Carcinoma, Ductal, Breast 3Radiation Injuries 2Neuroectodermal Tumors, Primitive, Peripheral 2Gliosarcoma 2Glioblastoma 2Esophageal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Anemia 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Retinoblastoma 1Recurrent Head and Neck Carcinoma 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1

Interventions

Ifosfamide 7Doxorubicin 6Radiotherapy 5Filgrastim 3Chemotherapy, Adjuvant 3Vincristine 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2vatalanib 1soblidotin 1romidepsin 1perifosine 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1Watchful Waiting 1Trabectedin 1Sunitinib 1Sorafenib 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Observation 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemangiopericytoma, Malignant × Brachytherapy × Clear all
NCT00002898 2013-12-04

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡